Advances in the management of metastatic bone disease

[1]  C. Rose,et al.  Non comparative multi centre open trial in patients with breast cancer and bone metastases to investigate the effect of apd (pamidronate) on bone healing, morbidity bone metabolism , 1993 .

[2]  J. Yarnold,et al.  Radiotherapy for bone metastasis are single and multiple fractions equivalent , 1993 .

[3]  A. Howell,et al.  Results of first line endocrine therapy for advanced breast cancer in premenopausal women with skeletal metastases only , 1993 .

[4]  J. M. Morrison,et al.  Parathyroid hormone-related protein: cytosol extraction in breast cancer and normal breast tissue , 1993 .

[5]  L. Mauriac,et al.  Delayed progression of bone metastases with bisphosphonate therapy: a randomised phase III trial with intravenous Aredia (pamidronate disodium) in breast cancer patients , 1993 .

[6]  P. Pitt,et al.  Treatment of bone metastases by aromatase inhibition with 4OH Androstenedione in women with advanced breast cancer , 1993 .

[7]  T. Martin,et al.  Parathyroid hormone related protein — a possible role in prediction of bone metastases early results of a prospective study , 1993 .

[8]  A. Howell,et al.  The effect of parathyroid hormone related protein on 1,25(OH)2 vitamin D in patients with breast cancer , 1993 .

[9]  J. Hermans,et al.  Palliative pamidronate treatment in patients with bone metastases from breast cancer. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  C. Tyrrell,et al.  A study of renal function of four infusions of Pamidronate 90 mg given over 60 minutes one week apart , 1993 .

[11]  R. Coleman,et al.  Osteoclast inhibition for the treatment of bone metastases. , 1993, Cancer treatment reviews.

[12]  T. Powles,et al.  Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  J. Ratcliffe,et al.  Role of assays for parathyroid-hormone-related protein in investigation of hypercalcaemia , 1992, The Lancet.

[14]  E. Bruera,et al.  A double-blind, crossover trial of intravenous clodronate in metastatic bone pain. , 1992, Journal of pain and symptom management.

[15]  L. Suva,et al.  PARATHYROID HORMONE‐RELATED PROTEIN IN HYPERCALCAEMIA OF MALIGNANCY , 1989, Clinical endocrinology.

[16]  J. Hayman,et al.  Parathyroid hormone‐related protein: Immunohistochemical localization in cancers and in normal skin , 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[17]  R. Rubens,et al.  The clinical course of bone metastases from breast cancer. , 1987, British Journal of Cancer.